Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 136

1.

Immune Parameters for Diagnosis and Treatment Monitoring in Invasive Mold Infection.

Jenks JD, Rawlings SA, Garcia-Vidal C, Koehler P, Mercier T, Prattes J, Lass-Flörl C, Martin-Gomez MT, Buchheidt D, Pagano L, Gangneux JP, van de Veerdonk FL, Netea MG, Carvalho A, Hoenigl M.

J Fungi (Basel). 2019 Dec 16;5(4). pii: E116. doi: 10.3390/jof5040116. Review.

2.

(New) Methods for Detection of Aspergillus fumigatus Resistance in Clinical Samples.

Jenks JD, Spiess B, Buchheidt D, Hoenigl M.

Curr Fungal Infect Rep. 2019 Sep;13(3):129-136. doi: 10.1007/s12281-019-00342-w. Epub 2019 Jun 20.

3.

Aspergillus specific nested PCR from the site of infection is superior to testing concurrent blood samples in immunocompromised patients with suspected invasive aspergillosis.

Boch T, Spiess B, Heinz W, Cornely OA, Schwerdtfeger R, Hahn J, Krause SW, Duerken M, Bertz H, Reuter S, Kiehl M, Claus B, Deckert PM, Hofmann WK, Buchheidt D, Reinwald M.

Mycoses. 2019 Nov;62(11):1035-1042. doi: 10.1111/myc.12983.

PMID:
31402465
4.

Management of sepsis in neutropenic cancer patients: 2018 guidelines from the Infectious Diseases Working Party (AGIHO) and Intensive Care Working Party (iCHOP) of the German Society of Hematology and Medical Oncology (DGHO).

Kochanek M, Schalk E, von Bergwelt-Baildon M, Beutel G, Buchheidt D, Hentrich M, Henze L, Kiehl M, Liebregts T, von Lilienfeld-Toal M, Classen A, Mellinghoff S, Penack O, Piepel C, Böll B.

Ann Hematol. 2019 May;98(5):1051-1069. doi: 10.1007/s00277-019-03622-0. Epub 2019 Feb 22. Review.

5.

Diagnostic work up to assess early response indicators in invasive pulmonary aspergillosis in adult patients with haematologic malignancies.

Heinz WJ, Vehreschild JJ, Buchheidt D.

Mycoses. 2019 Jun;62(6):486-493. doi: 10.1111/myc.12860. Epub 2019 Apr 29. Review.

PMID:
30329192
6.

Diagnosis of invasive fungal diseases in haematology and oncology: 2018 update of the recommendations of the infectious diseases working party of the German society for hematology and medical oncology (AGIHO).

Ruhnke M, Behre G, Buchheidt D, Christopeit M, Hamprecht A, Heinz W, Heussel CP, Horger M, Kurzai O, Karthaus M, Löffler J, Maschmeyer G, Penack O, Rieger C, Rickerts V, Ritter J, Schmidt-Hieber M, Schuelper N, Schwartz S, Ullmann A, Vehreschild JJ, von Lilienfeld-Toal M, Weber T, Wolf HH.

Mycoses. 2018 Nov;61(11):796-813. doi: 10.1111/myc.12838. Epub 2018 Sep 3. Review.

PMID:
30098069
7.

Detection of invasive pulmonary aspergillosis in critically ill patients by combined use of conventional culture, galactomannan, 1-3-beta-D-glucan and Aspergillus specific nested polymerase chain reaction in a prospective pilot study.

Boch T, Reinwald M, Spiess B, Liebregts T, Schellongowski P, Meybohm P, Rath PM, Steinmann J, Trinkmann F, Britsch S, Michels JD, Jabbour C, Hofmann WK, Buchheidt D.

J Crit Care. 2018 Oct;47:198-203. doi: 10.1016/j.jcrc.2018.07.001. Epub 2018 Jul 4.

PMID:
30015290
8.

Diagnosis of invasive aspergillosis in hematological malignancy patients: Performance of cytokines, Asp LFD, and Aspergillus PCR in same day blood and bronchoalveolar lavage samples.

Heldt S, Prattes J, Eigl S, Spiess B, Flick H, Rabensteiner J, Johnson G, Prüller F, Wölfler A, Niedrist T, Boch T, Neumeister P, Strohmaier H, Krause R, Buchheidt D, Hoenigl M.

J Infect. 2018 Sep;77(3):235-241. doi: 10.1016/j.jinf.2018.05.001. Epub 2018 Jul 1.

9.

Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy.

Jenks JD, Salzer HJ, Prattes J, Krause R, Buchheidt D, Hoenigl M.

Drug Des Devel Ther. 2018 Apr 30;12:1033-1044. doi: 10.2147/DDDT.S145545. eCollection 2018. Review.

10.

Consensus statement for cancer patients requiring intensive care support.

Kiehl MG, Beutel G, Böll B, Buchheidt D, Forkert R, Fuhrmann V, Knöbl P, Kochanek M, Kroschinsky F, La Rosée P, Liebregts T, Lück C, Olgemoeller U, Schalk E, Shimabukuro-Vornhagen A, Sperr WR, Staudinger T, von Bergwelt Baildon M, Wohlfarth P, Zeremski V, Schellongowski P; Consensus of the German Society of Hematology and Medical Oncology (DGHO), Austrian Society of Hematology and Oncology (OeGHO), German Society for Medical Intensive Care Medicine and Emergency Medicine (DGIIN), and Austrian Society of Medical and General Intensive Care and Emergency Medicine (ÖGIAIN).

Ann Hematol. 2018 Jul;97(7):1271-1282. doi: 10.1007/s00277-018-3312-y. Epub 2018 Apr 27.

11.

Anti-infective vaccination strategies in patients with hematologic malignancies or solid tumors-Guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO).

Rieger CT, Liss B, Mellinghoff S, Buchheidt D, Cornely OA, Egerer G, Heinz WJ, Hentrich M, Maschmeyer G, Mayer K, Sandherr M, Silling G, Ullmann A, Vehreschild MJGT, von Lilienfeld-Toal M, Wolf HH, Lehners N; German Society of Hematology and Medical Oncology Infectious Diseases Working Group (AGIHO).

Ann Oncol. 2018 Jun 1;29(6):1354-1365. doi: 10.1093/annonc/mdy117. Review.

12.

Comparison of Two Molecular Assays for Detection and Characterization of Aspergillus fumigatus Triazole Resistance and Cyp51A Mutations in Clinical Isolates and Primary Clinical Samples of Immunocompromised Patients.

Postina P, Skladny J, Boch T, Cornely OA, Hamprecht A, Rath PM, Steinmann J, Bader O, Miethke T, Dietz A, Merker N, Hofmann WK, Buchheidt D, Spiess B.

Front Microbiol. 2018 Mar 27;9:555. doi: 10.3389/fmicb.2018.00555. eCollection 2018.

13.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

14.

Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO).

Mellinghoff SC, Panse J, Alakel N, Behre G, Buchheidt D, Christopeit M, Hasenkamp J, Kiehl M, Koldehoff M, Krause SW, Lehners N, von Lilienfeld-Toal M, Löhnert AY, Maschmeyer G, Teschner D, Ullmann AJ, Penack O, Ruhnke M, Mayer K, Ostermann H, Wolf HH, Cornely OA.

Ann Hematol. 2018 Feb;97(2):197-207. doi: 10.1007/s00277-017-3196-2. Epub 2017 Dec 7. Review.

15.

Diagnosis and management of gastrointestinal complications in adult cancer patients: 2017 updated evidence-based guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Schmidt-Hieber M, Bierwirth J, Buchheidt D, Cornely OA, Hentrich M, Maschmeyer G, Schalk E, Vehreschild JJ, Vehreschild MJGT; AGIHO Working Group.

Ann Hematol. 2018 Jan;97(1):31-49. doi: 10.1007/s00277-017-3183-7. Epub 2017 Nov 24. Review.

16.

The evolving landscape of new diagnostic tests for invasive aspergillosis in hematology patients: strengths and weaknesses.

Buchheidt D, Reinwald M, Hoenigl M, Hofmann WK, Spiess B, Boch T.

Curr Opin Infect Dis. 2017 Dec;30(6):539-544. doi: 10.1097/QCO.0000000000000408. Review.

PMID:
28938246
17.

Molecular Tools for the Detection and Deduction of Azole Antifungal Drug Resistance Phenotypes in Aspergillus Species.

Dudakova A, Spiess B, Tangwattanachuleeporn M, Sasse C, Buchheidt D, Weig M, Groß U, Bader O.

Clin Microbiol Rev. 2017 Oct;30(4):1065-1091. doi: 10.1128/CMR.00095-16. Review.

18.

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H, Karthaus M, Link H, Mahlberg R, Neumann S, Ostermann H, Penack O, Ruhnke M, Sandherr M, Schiel X, Vehreschild JJ, Weissinger F, Maschmeyer G.

Ann Hematol. 2017 Nov;96(11):1775-1792. doi: 10.1007/s00277-017-3098-3. Epub 2017 Aug 30. Review.

19.

Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele.

Rößler S, Bader O, Stölzel F, Sommer U, Spiess B, Geibel S, Buchheidt D, Groß U, Baretton G, Jacobs E, Ostrosky-Zeichner L.

Antimicrob Agents Chemother. 2017 Jul 25;61(8). pii: e00270-17. doi: 10.1128/AAC.00270-17. Print 2017 Aug.

20.

Diagnostic Performance of Contrast Enhanced Pulmonary Computed Tomography Angiography for the Detection of Angioinvasive Pulmonary Aspergillosis in Immunocompromised Patients.

Henzler C, Henzler T, Buchheidt D, Nance JW, Weis CA, Vogelmann R, Benck U, Viergutz T, Becher T, Boch T, Klein SA, Heidenreich D, Pilz L, Meyer M, Deckert PM, Hofmann WK, Schoenberg SO, Reinwald M.

Sci Rep. 2017 Jun 30;7(1):4483. doi: 10.1038/s41598-017-04470-6.

21.

Evaluating the use of PCR for diagnosing invasive aspergillosis.

Buchheidt D, Reinwald M, Hofmann WK, Boch T, Spiess B.

Expert Rev Mol Diagn. 2017 Jun;17(6):603-610. doi: 10.1080/14737159.2017.1325735. Epub 2017 May 10. Review.

PMID:
28460550
22.

FunResDB-A web resource for genotypic susceptibility testing of Aspergillus fumigatus.

Weber M, Schaer J, Walther G, Kaerger K, Steinmann J, Rath PM, Spiess B, Buchheidt D, Hamprecht A, Kurzai O.

Med Mycol. 2018 Jan 1;56(1):117-120. doi: 10.1093/mmy/myx015.

23.

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study.

Koehler P, Hamprecht A, Bader O, Bekeredjian-Ding I, Buchheidt D, Doelken G, Elias J, Haase G, Hahn-Ast C, Karthaus M, Kekulé A, Keller P, Kiehl M, Krause SW, Krämer C, Neumann S, Rohde H, La Rosée P, Ruhnke M, Schafhausen P, Schalk E, Schulz K, Schwartz S, Silling G, Staib P, Ullmann A, Vergoulidou M, Weber T, Cornely OA, Vehreschild MJ.

Int J Antimicrob Agents. 2017 Feb;49(2):218-223. doi: 10.1016/j.ijantimicag.2016.10.019. Epub 2016 Dec 12.

PMID:
27989379
24.

[Antifungal medication: new substances, new experiences].

Buchheidt D, Hofmann WK.

Dtsch Med Wochenschr. 2016 Nov;141(24):1752-1756. Epub 2016 Nov 30. Review. German.

PMID:
27903025
25.

Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.

Eigl S, Hoenigl M, Spiess B, Heldt S, Prattes J, Neumeister P, Wolfler A, Rabensteiner J, Prueller F, Krause R, Reinwald M, Flick H, Buchheidt D, Boch T.

Med Mycol. 2017 Jul 1;55(5):528-534. doi: 10.1093/mmy/myw102.

26.

Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.

Boch T, Spiess B, Cornely OA, Vehreschild JJ, Rath PM, Steinmann J, Heinz WJ, Hahn J, Krause SW, Kiehl MG, Egerer G, Liebregts T, Koldehoff M, Klein M, Nolte F, Mueller MC, Merker N, Will S, Mossner M, Popp H, Hofmann WK, Reinwald M, Buchheidt D.

Clin Microbiol Infect. 2016 Oct;22(10):862-868. doi: 10.1016/j.cmi.2016.06.021. Epub 2016 Jul 5.

27.

Clinical evidence for caspofungin monotherapy in the first-line and salvage therapy of invasive Aspergillus infections.

Heinz WJ, Buchheidt D, Ullmann AJ.

Mycoses. 2016 Aug;59(8):480-93. doi: 10.1111/myc.12477. Epub 2016 Jun 21. Review.

PMID:
27324802
28.

CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Schmidt-Hieber M, Silling G, Schalk E, Heinz W, Panse J, Penack O, Christopeit M, Buchheidt D, Meyding-Lamadé U, Hähnel S, Wolf HH, Ruhnke M, Schwartz S, Maschmeyer G.

Ann Oncol. 2016 Jul;27(7):1207-25. doi: 10.1093/annonc/mdw155. Epub 2016 Apr 6.

29.

End-of-life decisions in acute stroke patients: an observational cohort study.

Alonso A, Ebert AD, Dörr D, Buchheidt D, Hennerici MG, Szabo K.

BMC Palliat Care. 2016 Apr 5;15:38. doi: 10.1186/s12904-016-0113-8.

30.

Biomarker-based diagnostic work-up of invasive pulmonary aspergillosis in immunocompromised paediatric patients--is Aspergillus PCR appropriate?

Buchheidt D, Reinwald M, Spiess B, Boch T, Hofmann WK, Groll AH, Lehrnbecher T; Working Group “Infections in Hematology and Oncology”, German Paul-Ehrlich-Society.

Mycoses. 2016 Feb;59(2):67-74. doi: 10.1111/myc.12443. Epub 2015 Dec 14. Review.

PMID:
26756571
31.

Direct comparison of galactomannan performance in concurrent serum and bronchoalveolar lavage samples in immunocompromised patients at risk for invasive pulmonary aspergillosis.

Boch T, Buchheidt D, Spiess B, Miethke T, Hofmann WK, Reinwald M.

Mycoses. 2016 Feb;59(2):80-5. doi: 10.1111/myc.12434. Epub 2015 Dec 2.

PMID:
26627577
32.

Identification of invasive fungal diseases in immunocompromised patients by combining an Aspergillus specific PCR with a multifungal DNA-microarray from primary clinical samples.

Boch T, Reinwald M, Postina P, Cornely OA, Vehreschild JJ, Heußel CP, Heinz WJ, Hoenigl M, Eigl S, Lehrnbecher T, Hahn J, Claus B, Lauten M, Egerer G, Müller MC, Will S, Merker N, Hofmann WK, Buchheidt D, Spiess B.

Mycoses. 2015 Dec;58(12):735-45. doi: 10.1111/myc.12424. Epub 2015 Oct 26.

PMID:
26497302
33.

Influence of mould-active antifungal treatment on the performance of the Aspergillus-specific bronchoalveolar lavage fluid lateral-flow device test.

Eigl S, Prattes J, Reinwald M, Thornton CR, Reischies F, Spiess B, Neumeister P, Zollner-Schwetz I, Raggam RB, Flick H, Buchheidt D, Krause R, Hoenigl M.

Int J Antimicrob Agents. 2015 Oct;46(4):401-5. doi: 10.1016/j.ijantimicag.2015.05.017. Epub 2015 Jun 30.

PMID:
26187363
34.

Early Palliative Care-Health services research and implementation of sustainable changes: the study protocol of the EVI project.

Meffert C, Gaertner J, Seibel K, Jors K, Bardenheuer H, Buchheidt D, Mayer-Steinacker R, Viehrig M, Paul C, Stock S, Xander C, Becker G.

BMC Cancer. 2015 May 29;15:443. doi: 10.1186/s12885-015-1453-0.

35.

Functional protease profiling for laboratory based diagnosis of invasive aspergillosis.

Sabbagh B, Costina V, Buchheidt D, Reinwald M, Neumaier M, Findeisen P.

Int J Oncol. 2015 Jul;47(1):143-50. doi: 10.3892/ijo.2015.2984. Epub 2015 May 4.

PMID:
25954923
36.

Multicenter evaluation of a lateral-flow device test for diagnosing invasive pulmonary aspergillosis in ICU patients.

Eigl S, Prattes J, Lackner M, Willinger B, Spiess B, Reinwald M, Selitsch B, Meilinger M, Neumeister P, Reischies F, Wölfler A, Raggam RB, Flick H, Eschertzhuber S, Krause R, Buchheidt D, Thornton CR, Lass-Flörl C, Hoenigl M.

Crit Care. 2015 Apr 17;19:178. doi: 10.1186/s13054-015-0905-x.

37.

Education in End-of-Life Care: What Do Experienced Professionals Find Important?

Jors K, Seibel K, Bardenheuer H, Buchheidt D, Mayer-Steinacker R, Viehrig M, Xander C, Becker G.

J Cancer Educ. 2016 Jun;31(2):272-8. doi: 10.1007/s13187-015-0811-6.

PMID:
25773135
38.

Therapeutic drug monitoring in the treatment of invasive aspergillosis with voriconazole in cancer patients--an evidence-based approach.

Karthaus M, Lehrnbecher T, Lipp HP, Kluge S, Buchheidt D.

Ann Hematol. 2015 Apr;94(4):547-56. doi: 10.1007/s00277-015-2333-z. Epub 2015 Feb 20. Review.

PMID:
25697592
39.

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany.

Steinmann J, Hamprecht A, Vehreschild MJ, Cornely OA, Buchheidt D, Spiess B, Koldehoff M, Buer J, Meis JF, Rath PM.

J Antimicrob Chemother. 2015 May;70(5):1522-6. doi: 10.1093/jac/dku566. Epub 2015 Jan 27.

PMID:
25630644
40.

Risk of Infectious Complications in Hemato-Oncological Patients Treated with Kinase Inhibitors.

Reinwald M, Boch T, Hofmann WK, Buchheidt D.

Biomark Insights. 2016 Apr 21;10(Suppl 3):55-68. doi: 10.4137/BMI.S22430. eCollection 2015. Review.

41.

Dying in cancer centers: do the circumstances allow for a dignified death?

Jors K, Adami S, Xander C, Meffert C, Gaertner J, Bardenheuer H, Buchheidt D, Mayer-Steinacker R, Viehrig M, George W, Becker G.

Cancer. 2014 Oct 15;120(20):3254-60. doi: 10.1002/cncr.28702. Epub 2014 Sep 8.

42.

Incidence of Cyp51 A key mutations in Aspergillus fumigatus-a study on primary clinical samples of immunocompromised patients in the period of 1995-2013.

Spiess B, Postina P, Reinwald M, Cornely OA, Hamprecht A, Hoenigl M, Lass-Flörl C, Rath PM, Steinmann J, Miethke T, Lauten M, Will S, Merker N, Hofmann WK, Buchheidt D.

PLoS One. 2014 Jul 29;9(7):e103113. doi: 10.1371/journal.pone.0103113. eCollection 2014.

43.

The risk of infections in hematologic patients treated with rituximab is not influenced by cumulative rituximab dosage - a single center experience.

Nissen JC, Hummel M, Brade J, Kruth J, Hofmann WK, Buchheidt D, Reinwald M.

BMC Infect Dis. 2014 Jul 3;14:364. doi: 10.1186/1471-2334-14-364.

44.

Primary prophylaxis of invasive fungal infections in patients with haematologic malignancies. 2014 update of the recommendations of the Infectious Diseases Working Party of the German Society for Haematology and Oncology.

Tacke D, Buchheidt D, Karthaus M, Krause SW, Maschmeyer G, Neumann S, Ostermann H, Penack O, Rieger C, Ruhnke M, Sandherr M, Schweer KE, Ullmann AJ, Cornely OA.

Ann Hematol. 2014 Sep;93(9):1449-56. doi: 10.1007/s00277-014-2108-y. Epub 2014 Jun 21. Review.

PMID:
24951122
45.

[Azole resistance in Aspergillus fumigatus - epidemiology and detection in immunocompromised patients in Germany].

Buchheidt D, Spiess B, Cornely OA, Vehreschild MJ, Hamprecht A, Rath PM, Steinmann J, Groß U, Bader O, Lauten M, Reinwald M, Hofmann WK.

Dtsch Med Wochenschr. 2014 Jun;139(25-26):1373-6. doi: 10.1055/s-0034-1370130. Epub 2014 Jun 10. Review. German. No abstract available.

PMID:
24914515
46.

Diagnosis and antimicrobial therapy of lung infiltrates in febrile neutropenic patients (allogeneic SCT excluded): updated guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).

Maschmeyer G, Carratalà J, Buchheidt D, Hamprecht A, Heussel CP, Kahl C, Lorenz J, Neumann S, Rieger C, Ruhnke M, Salwender H, Schmidt-Hieber M, Azoulay E; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2015 Jan;26(1):21-33. doi: 10.1093/annonc/mdu192. Epub 2014 May 15.

47.

Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO).

Penack O, Becker C, Buchheidt D, Christopeit M, Kiehl M, von Lilienfeld-Toal M, Hentrich M, Reinwald M, Salwender H, Schalk E, Schmidt-Hieber M, Weber T, Ostermann H.

Ann Hematol. 2014 Jul;93(7):1083-95. doi: 10.1007/s00277-014-2086-0. Epub 2014 Apr 29. Review.

48.

Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

Hoenigl M, Prattes J, Spiess B, Wagner J, Prueller F, Raggam RB, Posch V, Duettmann W, Hoenigl K, Wölfler A, Koidl C, Buzina W, Reinwald M, Thornton CR, Krause R, Buchheidt D.

J Clin Microbiol. 2014 Jun;52(6):2039-45. doi: 10.1128/JCM.00467-14. Epub 2014 Mar 26.

49.

Assessment of Aspergillus-specific PCR as a screening method for invasive aspergillosis in paediatric cancer patients and allogeneic haematopoietic stem cell recipients with suspected infections.

Reinwald M, Konietzka CA, Kolve H, Uhlenbrock S, Ahlke E, Hummel M, Spiess B, Hofmann WK, Buchheidt D, Groll AH.

Mycoses. 2014 Sep;57(9):537-43. doi: 10.1111/myc.12192. Epub 2014 Mar 21.

PMID:
24655146
50.

Central venous catheter-related infections in hematology and oncology: 2012 updated guidelines on diagnosis, management and prevention by the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Hentrich M, Schalk E, Schmidt-Hieber M, Chaberny I, Mousset S, Buchheidt D, Ruhnke M, Penack O, Salwender H, Wolf HH, Christopeit M, Neumann S, Maschmeyer G, Karthaus M; Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology.

Ann Oncol. 2014 May;25(5):936-47. doi: 10.1093/annonc/mdt545. Epub 2014 Jan 7.

Supplemental Content

Loading ...
Support Center